HEXAOM (ALHEX.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALHEX • FR0004159473

35.4 EUR
+0.2 (+0.57%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHEX. ALHEX was compared to 33 industry peers in the Household Durables industry. ALHEX has an average financial health and profitability rating. ALHEX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ALHEX was profitable.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • Of the past 5 years ALHEX 4 years were profitable.
  • ALHEX had a positive operating cash flow in each of the past 5 years.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • With a Return On Assets value of 1.46%, ALHEX perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • ALHEX has a Return On Equity of 3.94%. This is comparable to the rest of the industry: ALHEX outperforms 51.52% of its industry peers.
  • ALHEX has a Return On Invested Capital (3.70%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 9.38%.
  • The 3 year average ROIC (8.77%) for ALHEX is well above the current ROIC(3.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALHEX has declined.
  • Looking at the Operating Margin, with a value of 2.30%, ALHEX is doing worse than 60.61% of the companies in the same industry.
  • ALHEX's Operating Margin has declined in the last couple of years.
  • ALHEX has a Gross Margin of 21.14%. This is amonst the worse of the industry: ALHEX underperforms 81.82% of its industry peers.
  • ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALHEX is still creating some value.
  • ALHEX has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ALHEX has an improved debt to assets ratio.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.15 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.15, ALHEX perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
  • ALHEX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALHEX (0.40) is better than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACC0.52
WACC7.15%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that ALHEX should not have too much problems paying its short term obligations.
  • ALHEX's Current ratio of 1.31 is in line compared to the rest of the industry. ALHEX outperforms 42.42% of its industry peers.
  • ALHEX has a Quick Ratio of 1.31. This is a bad value and indicates that ALHEX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.99, ALHEX is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for ALHEX have decreased strongly by -68.84% in the last year.
  • Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
  • ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.53%.
  • ALHEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.93% yearly.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • The Earnings Per Share is expected to grow by 37.93% on average over the next years. This is a very strong growth
  • ALHEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.02% yearly.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 27.02, the valuation of ALHEX can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALHEX is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of ALHEX to the average of the S&P500 Index (28.18), we can say ALHEX is valued inline with the index average.
  • A Price/Forward Earnings ratio of 8.81 indicates a reasonable valuation of ALHEX.
  • ALHEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALHEX is cheaper than 66.67% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALHEX to the average of the S&P500 Index (25.51), we can say ALHEX is valued rather cheaply.
Industry RankSector Rank
PE 27.02
Fwd PE 8.81
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ALHEX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.65
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHEX does not grow enough to justify the current Price/Earnings ratio.
  • ALHEX's earnings are expected to grow with 37.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.08
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

  • ALHEX has a Yearly Dividend Yield of 1.35%.
  • Compared to an average industry Dividend Yield of 2.76, ALHEX has a dividend in line with its industry peers.
  • Compared to the average S&P500 Dividend Yield of 1.83, ALHEX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

More info and screens

HEXAOM

EPA:ALHEX (2/3/2026, 7:00:00 PM)

35.4

+0.2 (+0.57%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-07
Earnings (Next)02-10
Inst Owners15.33%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap245.68M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86.67
Price Target46.41 (31.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.67%
EPS NY rev (3m)-22.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.02
Fwd PE 8.81
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB 2.42
EV/EBITDA 6.65
EPS(TTM)1.31
EY3.7%
EPS(NY)4.02
Fwd EY11.35%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)11.08
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.15
F-Score4
WACC7.15%
ROIC/WACC0.52
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHEX.PA.


What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 27.02 and the Price/Book (PB) ratio is 1.07.


Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 4 / 10.